Daily Archives: July 18, 2013

Featured Stories
Conspiracy Claims in Talcum Powder Case Survive Motion to Dismiss

Conspiracy Claims in Talcum Powder Case Survive Motion to Dismiss

E. District of Missouri denied motion to dismiss conspiracy claims. Lawsuit alleges the defendants conspired to misrepresent true dangers with use of talcum powder.

Read More

Actos, Avandia May Up Risk for Diabetic Macular Edema

A newly published study is raising concerns that patients who take Actos or Avandia may face an increased risk of developing diabetic macular edema, an eye disorder that can result in vision loss. The study, published in the Archives of Internal Medicine, found that type 2 diabetics who use thiazolidinediones, ...

Read More

FDA Metal-On-Metal Hip Replacement Investigation Is Flawed, Researchers Say

The U.S. Food & Drug Administration’s (FDA) metal-on-metal hip replacement investigation is flawed, according to researchers.

Read More

Zadroga Act Cancer Decision Expected This Week

The federal official tasked with determining what ailments should be covered by the federal Zadroga Act is expected to decide by Saturday if certain cancers will be eligible for compensation. The decision is being eagerly awaited by thousands of first responders who believe they developed cancer due to exposure ...

Read More

Cancer Groups Call for E-cigarettes Regulation/Research

Two Leading Cancer Groups Issue Call for Regulation of E-cigarettes and Research on Health Risks

In a joint statement, the American Society of Clinical Oncology and the American Association for Cancer Research have called on the federal government to move quickly to regulate e-cigarettes and increase research on their health effects. These leading research and treatment organizations asked the Food and Drug Administration (FDA) to make ...

Read More

British Recall of Smith & Nephew Renasys Wound Care System

British Recall of Smith & Nephew Renasys Wound Care System for Infection Risk

The MHRA announced the recall of Smith & Nephew Renasys wound care devices - risk of maceration, infection, loss of negative pressure, or unrecognized bleeding in wounds.

Read More

Birth Control Shot Depo-Provera may Increase HIV Risk

Birth Control Shot Depo-Provera may Increase HIV Risk, Study Suggests

A new study has linked the use of Depo-Provera (medroxyprogesterone acetate), an injectable type of birth control, to an increased risk of HIV infection.

Read More

Lawsuit Alleges Bi-Lateral DePuy ASR Hip Implant Resulted in Elevated Chromium and Cobalt Levels, Need for Revision Surgery

DePuy Orthopaedics and its parent, Johnson & Johnson, continue to be named in lawsuits by metal-on-metal hip replacement recipients who suffered severe injuries, including elevated chromium and cobalt levels, allegedly due to recalled ASR hip implant devices. Most recently, the national law firm of Parker Waichman LLP filed suit on ...

Read More

Colorado Woman Sues American Medical Systems Over Transvaginal Mesh Injuries

Parker Waichman LLP, a national law firm, just filed a lawsuit on behalf of a Colorado woman allegedly injured by transvaginal mesh products manufactured by American Medical Systems, Inc. The suit was filed on May 21, 2012 in the U.S. District Court for the Northern District of California (Case No. ...

Read More

Boston Scientific Transvaginal Mesh

Tennessee Woman Alleges Boston Scientific Transvaginal Mesh Product Caused Painful Injuries

More reports of painful injuries are being linked to transvaginal mesh. This time, a Tennessee woman has filed a lawsuit against Boston Scientific over its Advantage Transvaginal Mid-Urethral Sling System.

Read More

Novartis Drug Gilenya Leads to Government Investigations, Safety Concerns

novartis_gilenya_investigations

Novartis’ Gilenya, a drug used to treat multiple sclerosis, is under investigation over allegations that the company paid kickbacks to healthcare providers for using the medication. The probe isn’t the first for Novartis. In the past year, the company has … Continue reading

Posted in Legal News |

Sears Issues Another Dehumidifier Recall Due to Fire Hazard

sears_dehumidifier_recall

Sears is implementing another recall of its Kenmore dehumidifiers over risk of fire, according to the U.S. Consumer Product Safety Commission (CPSC). The recalled Kenmore dehumidifiers can overheat, smoke, melt, and catch on fire, which poses fire and burn hazards … Continue reading

Posted in Defective Products |

Celegen Trial Ceased Over Deaths

celegen_revlimid_trial_stopped

Drug maker, Celgene Corp., ceased a Revlimid (lenalidomide) trial following a number of deaths. Revlimid is Celgene’s largest selling drug. The study revealed that more people who were taking Revlimid died when compared to those who were taking a competitor’s … Continue reading

Posted in Pharmaceuticals |

Pending Sunshine Act to Focus on Allegedly Fraudulent Financial Ties Between Physicians and Industry

sunshine_act_physicians

On August 1, the Physician Payment Sunshine Act provision of the Affordable Care Act will go into effect. The Act is meant to highlight allegedly bogus relationships between physicians and pharmaceutical firms and medical device manufacturers. As we’ve long stressed, … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

Texas Man Files Lawsuit Alleging Actos Caused His Bladder Cancer

texas_actos_bladder_cancer_lawsuit

A Texas man has filed a lawsuit in the U.S. District Court for the Western District of Louisiana (Case No. 6:13-cv-02229) alleging that the diabetes drug Actos is to blame for his bladder cancer. This case is one of thousands … Continue reading

Posted in Actos, Health Concerns, Pharmaceuticals |

FDA Examining Mounting Salmonella Contamination Risks

salmonella_nut_contaminations

The U.S. Food and Drug Administration (FDA) is looking into Salmonella risks four years after a massive recall related to tainted nuts. That recall, according to Bloomberg News, was associated with nine deaths and is considered one of the largest … Continue reading

Posted in Food Poisoning, Salmonella |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.